Down 37% in 4 Weeks, Here's Why Aquestive Therapeutics (AQST) Looks Ripe for a TurnaroundZacks Investment Research • 01/12/26
INVESTOR ALERT: Investigation of Aquestive Therapeutics, Inc. (AQST) by Holzer & Holzer, LLCGlobeNewsWire • 01/09/26
BREAKING: Aquestive Therapeutics Investigated for Securities Fraud After FDA Identifies Deficiencies; Investors Should Contact Block & Leviton To Potentially Recover LossesGlobeNewsWire • 01/09/26
Aquestive Therapeutics Announces Regulatory Development for Anaphylm™ (dibutepinephrine) Sublingual Film and Provides Business UpdateGlobeNewsWire • 01/09/26
Aquestive Therapeutics, Inc. (AQST) Discusses Anaphylm Regulatory Progress, Commercial Strategy, and Pipeline Development TranscriptSeeking Alpha • 11/07/25
Here's What Key Metrics Tell Us About Aquestive Therapeutics (AQST) Q3 EarningsZacks Investment Research • 11/06/25
Aquestive Therapeutics (AQST) Reports Q3 Loss, Lags Revenue EstimatesZacks Investment Research • 11/05/25
Aquestive Therapeutics to Report Third Quarter 2025 Financial Results and Recent Business Highlights on November 5 and Host Conference Call on November 6 at 8:00 a.m. ETGlobeNewsWire • 10/27/25
Are Medical Stocks Lagging Aquestive Therapeutics (AQST) This Year?Zacks Investment Research • 10/15/25
Aquestive Therapeutics (AQST) Surges 7.9%: Is This an Indication of Further Gains?Zacks Investment Research • 10/10/25
Aquestive Therapeutics (AQST) Soars 14.8%: Is Further Upside Left in the Stock?Zacks Investment Research • 09/22/25
Aquestive Therapeutics: No AdCom For Anaphylm Derisks January Approval CatalystSeeking Alpha • 09/05/25
AQST Stock Up as FDA Skips Advisory Meeting to Discuss Anaphylm NDAZacks Investment Research • 09/05/25
Is Aquestive Therapeutics (AQST) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 08/14/25
Aquestive Therapeutics Announces Pricing of $85 Million Underwritten Offering of Common StockGlobeNewsWire • 08/14/25
Aquestive Therapeutics Announces $75M Strategic Funding Agreement with RTW to Support the Potential Launch of Anaphylm™ (epinephrine) Sublingual FilmGlobeNewsWire • 08/14/25
Compared to Estimates, Aquestive Therapeutics (AQST) Q2 Earnings: A Look at Key MetricsZacks Investment Research • 08/12/25
Aquestive Therapeutics (AQST) Reports Q2 Loss, Lags Revenue EstimatesZacks Investment Research • 08/11/25